Assignee
NORTHWEST BIOTHERAPEUTICS INC
US·11 granted patents·14 pending applications·228 citations·filing 1998–2021
Top patents by PatentIndex Score
25 records- 0194US6150508AMonoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigenNORTHWEST BIOTHERAPEUTICS INC·Filed 1998·Granted Nov 21, 2000·140 cites·16 claims
- 0289US7695627B2Tangential flow filtration devices and methods for leukocyte enrichmentNORTHWEST BIOTHERAPEUTICS INC·Filed 2003·Granted Apr 13, 2010·46 cites·45 claims
- 0382US9102917B2Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokinesNORTHWEST BIOTHERAPEUTICS INC·Filed 2013·Granted Aug 11, 2015·3 cites·17 claims
- 0481US6936448B2Nucleic acids and proteins of a rat ganglioside GM1-specific α1-2fucosyltransferase and uses thereofNORTHWEST BIOTHERAPEUTICS INC·Filed 2001·Granted Aug 30, 2005·10 cites·20 claims
- 0572US7790039B2Tangential flow filtration devices and methods for stem cell enrichmentNORTHWEST BIOTHERAPEUTICS INC·Filed 2004·Granted Sep 7, 2010·9 cites·27 claims
- 0670US11827903B2Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokinesNORTHWEST BIOTHERAPEUTICS INC·Filed 2020·Granted Nov 28, 2023·0 cites·22 claims
- 0770US6863887B1Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesisNORTHWEST BIOTHERAPEUTICS INC·Filed 1999·Granted Mar 8, 2005·20 cites·19 claims
- 0866US2022145246A1Optimally activated dendritic cells that induce an improved or increased anti-tumor immune responseNORTHWEST BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0961US2017363625A1Quality assays for antigen presenting cellsNORTHWEST BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1059US10731130B2Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokinesNORTHWEST BIOTHERAPEUTICS INC·Filed 2015·Granted Aug 4, 2020·0 cites·21 claims
- 1159US9566294B2Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesisNORTHWEST BIOTHERAPEUTICS INC·Filed 2013·Granted Feb 14, 2017·0 cites·8 claims
- 1257US2010008892A1Quality assays for antigen presenting cellsNORTHWEST BIOTHERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1357US2006057120A1Administration of dendritic cells partially matured in vitro for the treatment of tumorsNORTHWEST BIOTHERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 1456US11124768B2Optimally activated dendritic cells that induce an improved or increased anti-tumor immune responseNORTHWEST BIOTHERAPEUTICS INC·Filed 2016·Granted Sep 21, 2021·0 cites·11 claims
- 1556US2008171023A1Method to increase class i presentation of exogenous antigens by human dendritic cellsNORTHWEST BIOTHERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 1656US2008254064A1Compositions and methods for priming monocytic dendritic cells and t cells for th-1 responseNORTHWEST BIOTHERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 1755US2005202019A1Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesisNORTHWEST BIOTHERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 1854US2006234286A1Human paris-1 antigen and nucleic acids: diagnostic and therapeutic usesNORTHWEST BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1953US2008254537A1Compositions and Methods for Inducing the Activation of Immature Monocytic Dendritic CellsNORTHWEST BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2052US2024122975A1In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, and for inducing a th-1 immune responseNORTHWEST BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2152US2004197903A1Method for induction of proliferation of natural killer cells by dendritic cells cultured with GM-CSF and IL-15NORTHWEST BIOTHERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 2250US2013017600A1Isolation and/or preservation of dendritic cells for prostate cancer immunotherapyNORTHWEST BIOTHERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 2347US7087715B2Human paris-1 antigen and nucleic acids: diagnostic and therapeutic usesNORTHWEST BIOTHERAPEUTICS INC·Filed 2001·Granted Aug 8, 2006·0 cites·5 claims
- 2447US2006234309A1Quality assays for antigen presenting cellsNORTHWEST BIOTHERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 2540US2019046568A1Methods relating to activated dendritic cell compositions and immunotherapeutic treatments for subjects with advanced cancersNORTHWEST BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NORTHWEST BIOTHERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →